Full Text View
Tabular View
No Study Results Posted
Related Studies
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
This study has been terminated.
( The development program has been terminated )
Study NCT00229684   Information provided by AstraZeneca

First Received on September 28, 2005.   Last Updated on August 29, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial